Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2000
12/13/2000EP1058738A2 A fluorescence polarization screening method
12/13/2000EP1058737A1 Novel fdrg protein and nucleic acid molecules and uses therefor
12/13/2000EP1058733A2 Methods and compositions for regulating cell death and enhancing disease resistance to plant pathogens
12/13/2000EP1058732A2 Attenuation of bacteria: materials and methods relating thereto
12/13/2000EP1058731A2 Production of mycobacterial polypeptides by lactic acid bacteria
12/13/2000EP1058730A1 Human synapse related glycoproteins (hsrp)
12/13/2000EP1058729A1 Smad binding elements and uses thereof
12/13/2000EP1058728A1 V-like domain binding molecules
12/13/2000EP1058727A1 Materials and methods for identifying and analyzing intermediate tandem repeat dna markers
12/13/2000EP1058726A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
12/13/2000EP1058724A1 Maltogenic alpha-amylase variants
12/13/2000EP1058723A1 Delivery of proteins into eukaryotic cells with recombinant yersinia
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058500A1 The helios gene
12/13/2000EP0914144B1 Therapeutic uses of bpi protein products for human meningococcemia
12/13/2000EP0778781B1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
12/13/2000EP0601062B2 Sirs vaccine and diagnosis method
12/13/2000EP0444115B2 In situ suppression hybridization and uses therefor
12/13/2000CN1276836A Positive-negative selection for homologous recombination
12/13/2000CN1276835A Universal chloroplast integration and expression vectors, transformed plants and products thereof
12/13/2000CN1276834A Modified nucleic acid sequences and method for increasing mRNA level and protein expression in cell system
12/13/2000CN1276833A Vaccine
12/13/2000CN1276832A Composition and method for identifying PKB kinase inhibitors
12/13/2000CN1276831A Modified nucleic acid sequences and method for increasing mRNA levels and protein expression in cell systems
12/13/2000CN1276830A Single-stranded antibody against hepatitis B virus core protein, gene thereof, and therapeutic agent for hepatitis B contg. these
12/13/2000CN1276797A Low-toxicity human interferon-alpha analog
12/13/2000CN1276796A Biomolecules comprising elastomeric peptide
12/13/2000CN1276794A Triplex forming oligonucleotides and their use in anti-HBV
12/13/2000CN1276729A Heparin-binding growth factor (HBGF) polypeptides
12/13/2000CN1276726A Method for treating hypercoagulable states or acquired protein C deficiency
12/13/2000CN1276429A Clone of rice Xanthomonas hrp gene and regulatory gene of hrp gene
12/13/2000CN1276428A Clone and expression of anti-CA125 bifunctional genetically engineered antibody
12/13/2000CN1276427A Process for preparing allelic gene step of shortly serial repetitive sequence
12/13/2000CN1276421A Method for production of L-arginine
12/13/2000CN1276380A Human reduced nicotinamide adenine nucleotie-cytochrome b5 reductase and its coding sequence
12/13/2000CN1276379A Polypeptide-thyrocalcitonin 11 and polynucleotide for coding same
12/13/2000CN1059466C Method for identifying individuals suffering from cellular abnormality
12/13/2000CN1059465C Method for diagnosing disorder by determining expression of GAGE tumor rejection antigen precursors
12/13/2000CN1059447C Polypeptide toxins from spider
12/12/2000US6160208 Genetically engineered cells which express a seed storage protein; for amplification of lysine, methionine and threonine in seeds
12/12/2000US6160206 Porphyrin-accumulating type herbicide resistance gene
12/12/2000US6160205 Transgenic plant cell with increased disease resistance
12/12/2000US6160204 Polyphenol oxidase cDNA
12/12/2000US6160203 Chimeric dna from spinach and squash; for transgenic plants with altered unsaturated fatty acid composition and with chilling resistance
12/12/2000US6160202 Regulatory protein which is expressed in recombinant dicot; for modulation of expression of preferential genes
12/12/2000US6160201 Lettuce infectious yellows virus genes
12/12/2000US6160109 Preparation of phosphorothioate and boranophosphate oligomers
12/12/2000US6160108 Platelet activation protein
12/12/2000US6160106 Nucleotide sequences which code polypeptides which prevent gene expression; for use as diagnostic screening tools in the detection and treatment of cancer; anticarcinogenic agents
12/12/2000US6160103 Conjugates of an oligonucleotide/electronic conductor polymer with a molecule of interest, and their uses
12/12/2000US6160100 Treatment for wilt diseases of trees
12/12/2000US6160099 Anti-human αv β3 and αv β5 antibodies
12/12/2000US6160098 Preparing a fixed erythrocyte transport protein having preferential physical properties; obtain deoxygenated erythrocyte transport protein and controlling physical properties of solution during fixation
12/12/2000US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds
12/12/2000US6160091 Transcription factor; for the treatment of genetic disorders; for gene therapy
12/12/2000US6160089 Cellular signal for the expression of mammalian somatotropin; for the amplification of somatotropin in cells
12/12/2000US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
12/12/2000US6160024 Photoactivated antiviral and antitumor compositions
12/12/2000US6160021 Administering to the subject a treatment which modulates the level of nitric oxide in the skin
12/12/2000US6159951 2'-O-amino-containing nucleoside analogs and polynucleotides
12/12/2000US6159949 Polynucleotides, codes and amino acid sequences
12/12/2000US6159947 Isolation of nucleic acids and gene codes
12/12/2000US6159946 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells
12/12/2000US6159937 Immunomodulators
12/12/2000US6159936 Microbiocides or viricides
12/12/2000US6159934 Use of GHRH-RP to stimulate stem cell factor production
12/12/2000US6159751 Development of DNA probes and immunological reagents of human tumor associated antigens
12/12/2000US6159738 Method for construction of bacterial strains with increased succinic acid production
12/12/2000US6159737 Amplifying transfer of genetic material into tissue by incubation of tissue with growth factor and chromosomal protein
12/12/2000US6159736 Method for making insertional mutations using a Tn5 synaptic complex
12/12/2000US6159734 Nucleotide sequences which prevent or reduce transcription of human gene; for the treatment of non-insulin dependent diabetes, cardiovascular disorders and gastrointestinal disorders; antiinflammatory agents; anticarcinogenic agents
12/12/2000US6159732 Nucleic acid encoding mammalian Ubr1
12/12/2000US6159730 Expression vector having a marker with translation start site with a fully impaired consensus kozak sequence; marker is co-linked to a nucleic acid encoding an anti-cd20 antibody
12/12/2000US6159729 For recombinant production and vaccines
12/12/2000US6159728 Capsid formed from a coat protein of a bacteriophage and enclosing a foreign moiety linked to an rna sequence of a bacteriophage translational operator which binds to the coat protein; drug delivery; gene therapy
12/12/2000US6159725 Transformed yeast strains
12/12/2000US6159722 First catalytic domain half of a factor xa linked to the second catalytic domain half of trypsin; anticoagulants with reduced side effects
12/12/2000US6159720 Enzyme endoglucanase and cellulase preparations containing the same
12/12/2000US6159718 Enzyme with polygalacturonase activity
12/12/2000US6159717 Dna and amino acid sequences for transposase protein related to minos-1; stable introduction of dna into a cell; transgenic animals; oligonucleotide primers for isolation of related sequences
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/12/2000US6159714 Catalytic DNA
12/12/2000US6159713 Methods for producing probes capable of distinguishing DNA from related sources
12/12/2000US6159712 Methods for enhancing the production of interferon in cell culture
12/12/2000US6159711 Amino acid sequences; antiinflammatory agents; treatment of asthma, allergic rhinitis or atopic dermatitis
12/12/2000US6159710 Method and compositions for stabilizing unstable gene transcripts
12/12/2000US6159709 XIAP IRES and uses thereof
12/12/2000US6159708 Chaperone expression plasmids
12/12/2000US6159705 Screening by using yeast cell which expresses a heterologous receptor which is functionally integrated into an endogenous yeast signaling pathway, contacting with a test compound, and detecting alteration in signal
12/12/2000US6159704 Phosphatase modulator
12/12/2000US6159700 Method of finding agonist and antagonist to human and rat GPR14
12/12/2000US6159697 Antisense modulation of Smad7 expression
12/12/2000US6159696 Isolated human BMP-4 promoter region
12/12/2000US6159695 High surface density covalent immobilization of oligonucleotide monolayers
12/12/2000US6159694 Antisense modulation of stat3 expression
12/12/2000US6159692 Enzymatic nucleic acid which specifically cleaves rna of the nef gene; viricides
12/12/2000US6159690 Digesting parent polynucleotide with exonuclease, contacting fragments with template under annealing conditions, then amplifying to generate polynucleotides which encode protein motifs with altered characteristics; enzymes; antibodies
12/12/2000US6159688 Methods of producing polynucleotide variants
12/12/2000US6159687 Methods for generating recombined polynucleotides
12/12/2000US6159478 Genetic engineering
1 ... 3142 3143 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 3161 3162 ... 4023